Angelina M. Lombardo v. HHS - Tdap, infected inflammatory granulomatous lesion and abscess (2023)
Case summary [AI summaries can sometimes make mistakes]
Angelina Lombardo filed a petition for compensation under the National Vaccine Injury Compensation Program on November 5, 2021. She alleged that she developed an infected inflammatory granulomatous lesion, abscess, and scar as a result of a tetanus-diphtheria-acellular pertussis (Tdap) vaccine she received on April 16, 2019.
The respondent, the Secretary of Health and Human Services, conceded entitlement to compensation, concluding that Ms. Lombardo's condition was more likely than not caused by the Tdap vaccine.
A ruling on entitlement was issued on May 9, 2023, finding her eligible for compensation. Subsequently, on August 2, 2023, a decision awarding damages was issued.
The parties stipulated to an award of $45,000.00 for pain and suffering and $1,820.23 to satisfy a New York State Medicaid lien, totaling $46,820.23. Ms.
Lombardo is a competent adult, and the award covers all damages available under the Vaccine Act.